Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: .31 .318

We own 50% of an asset that is proving to be worth well over $2 billion (perhaps over $3b); over $1 billion to PTSC alone, yet our market cap is $124 million, a TENTH of its intrinsic value.

Can our present board extract the value, and if not, will they get out of the way so those that can, will?







Share
New Message
Please login to post a reply